Literature DB >> 32444489

Time to activin on pathogenic T cells.

Anna Ebering1, Ari Waisman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32444489      PMCID： PMC7293638          DOI： 10.1073/pnas.2008491117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  B cells assume the command.

Authors:  Ari Waisman; Thomas Korn
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

2.  Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

Authors:  Simone Kern; Michael Geiger; Madlen Paucke; Alina Kästner; Katja Akgün; Tjalf Ziemssen
Journal:  J Mol Med (Berl)       Date:  2019-08-30       Impact factor: 4.599

3.  Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.

Authors:  Ioannis Morianos; Aikaterini I Trochoutsou; Gina Papadopoulou; Maria Semitekolou; Aggelos Banos; Dimitris Konstantopoulos; Antigoni Manousopoulou; Maria Kapasa; Ping Wei; Brett Lomenick; Elise Belaidi; Themis Kalamatas; Klinta Karageorgiou; Triantafyllos Doskas; Federica Sallusto; Fan Pan; Spiros D Garbis; Francisco J Quintana; Georgina Xanthou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-14       Impact factor: 11.205

4.  Dietary phytol reduces clinical symptoms in experimental autoimmune encephalomyelitis (EAE) at least partially by modulating NOX2 expression.

Authors:  Leonard Blum; Nadja Tafferner; Ilknur Spring; Jennifer Kurz; Natasja deBruin; Gerd Geisslinger; Michael J Parnham; Susanne Schiffmann
Journal:  J Mol Med (Berl)       Date:  2018-08-27       Impact factor: 4.599

5.  Genetic proof for the transient nature of the Th17 phenotype.

Authors:  Florian C Kurschus; Andrew L Croxford; André P Heinen; Simone Wörtge; Daniele Ielo; Ari Waisman
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

Review 6.  Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis.

Authors:  Sudhir Kumar Yadav; Devika Soin; Kouichi Ito; Suhayl Dhib-Jalbut
Journal:  J Mol Med (Berl)       Date:  2019-02-28       Impact factor: 4.599

Review 7.  Mouse models for multiple sclerosis: historical facts and future implications.

Authors:  Andrew L Croxford; Florian C Kurschus; Ari Waisman
Journal:  Biochim Biophys Acta       Date:  2010-06-25

8.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

9.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

Review 10.  Targeting senescence to delay progression of multiple sclerosis.

Authors:  Wendy Oost; Nynke Talma; Jan F Meilof; Jon D Laman
Journal:  J Mol Med (Berl)       Date:  2018-09-18       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.